Purdue Buys Time For Creditor Deal, Eletson Plan Confirmed
Facing a litigation stay deadline after the U.S. Supreme Court overturned its Chapter 11 plan, OxyContin maker Purdue Pharma was given a new one-month extension of the stay so that its...To view the full article, register now.
Already a subscriber? Click here to view full article